3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic states for the development of new anticancer strategies has been amply demonstrated. However, there is little or no information in the literature on the problems of reproducibility of data originating from experiments using 3D models. Our analyses, carried out using a novel open source software capable of performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology parameters affect the response of large spheroids to treatment. In particular, we found that both spheroid volume and shape may be a source of variability. We also compared some commercially available viability assays specifically designed for 3D models. In conclusion, our data indicate the need for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter in 650 μm by different kinds of treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent progress has directed the development of high-throughput methods for uniform spheroid assembly and continuous perfusable culture that secure reproducibility [92].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commercial kits, such as CellTiter-Glo® 3D and Cultrex® 3D viability assays, are designed to enhance lysis efficiency and signal uniformity in spheroids [15,307].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy
Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., & Stelzer, E. H. K. (2004) · Science · doi:10.1126/science.1100035 · Cited by 2,355
Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336 · cited 1×
“(5) The final volume is automatically estimated by counting the voxels bound by the surface and using the x-y pixel resolution coefficient to convert voxels to μ M3.”
MethodOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Spherical Cancer Models in Tumor Biology
Weiswald, L.-B., Bellet, D., & Dangles-Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,141
Cited by
Items 301–400 of 1,000
Lugand, L., Mestrallet, G., Laboureur, R., Dumont, C., Bouhidel, F. A., Djouadou, M., Masson-Lecomte, A., Desgrandchamps, F., Culine, S., Carosella, E. D., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.898732 · Cited by 33
Petrikaitė, V., d’Avanzo, N., Celia, C., & Fresta, M. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100956 · Cited by 33
Tumor Organoid and Spheroid Models for Cervical Cancer
Kutle, I., Polten, R., Hachenberg, J., Klapdor, R., Morgan, M. A., & Schambach, A. (2023) · Cancers · doi:10.3390/cancers15092518 · Cited by 33
Stossi, F., Singh, P. K., Safari, K., Marini, M., Labate, D., & Mancini, M. A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115770 · Cited by 33
“A standard assay upgrade is to grow canonical 2D cell models in 3D systems that more closely represent the in vivo growth and organization of the cells [151 – 157]; typically, this can be through either low attachment systems or embedding into extracellular matrixes (ECM).”
MethodPiccinini, F., Tesei, A., & Bevilacqua, A. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.07.024 · Cited by 33
Self-citationTotti, S., Vernardis, S. I., Meira, L. B., Pérez-Mancera, P. A., Costello, E., Greenhalf, W., Palmer, D. H., Neoptolemos, J. P., Mantalaris, A., & Velliou, E. G. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.012 · Cited by 33
Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
Saulīte, L., Pleiko, K., Popēna, I., Dapkutė, D., Rotomskis, R., & Riekstiņa, U. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.32 · Cited by 33
3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles
Daunys, S., Janonienė, A., Januškevičienė, I., Paškevičiūtė, M., & Petrikaitė, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_11 · Cited by 32
Calitz, C., Hamman, J. H., Fey, S. J., Wrzesinski, K., & Gouws, C. (2018) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2017.1422580 · Cited by 32
Adjustable and Versatile 3D Tumor Spheroid Culture Platform with Interfacial Elastomeric Wells
An, H. J., Kim, H. S., Kwon, J. A., Song, J., & Choi, I. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21471 · Cited by 32
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
Rupp, T., Pelouin, O., Genest, L., Legrand, C., Froget, G., & Castagné, V. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100926 · Cited by 32
“The 3D tumor spheroid model has the advantage of mimicking the complexity and heterogeneity of tumors observed in patients [ 39 , 40 ].”
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
Roper, S. J., & Coyle, B. (2022) · Current Protocols · doi:10.1002/cpz1.357 · Cited by 32
“This has led to 3D spheroids being widely utilized in disease modeling, drug evaluation, and studies of cell migration and invasion (Friedrich et al., 2009; Mittler et al., 2017; Vinci et al., 2012, 2013; Zanoni et al., 2016).”
MethodRisk stratification in GIST: shape quantification with CT is a predictive factor
Wei, S., Xu, L., Li, W., Li, Y., Guo, S.-F., Sun, X.-R., & Li, W. (2020) · European Radiology · doi:10.1007/s00330-019-06561-6 · Cited by 31
Transfecting tissue models with CRISPR/Cas9 plasmid DNA using peptide dendrimers
Zamolo, S., Darbre, T., & Reymond, J. (2020) · Chemical Communications · doi:10.1039/d0cc04750c · Cited by 31
Henrique, R. B. L., Lima, R. R. M., Monteiro, C. A. P., de Oliveira, W. F., Pereira, G., Filho, P. E. C., & Fontes, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120657 · Cited by 31
Kim, C., Zhu, Z., Barbazuk, W. B., Bacher, R. L., & Vulpe, C. D. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.10.004 · Cited by 31
Cancer drug discovery: recent innovative approaches to tumor modeling
Lovitt, C. J., Shelper, T., & Avery, V. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1214562 · Cited by 31
“have recently become available for use in 3D cell culture assays, such as the CellTiter-Glo 3D Cell Viability Assay, which has been specifically optimized for detection of cell viability in 3D systems through quantitation of adenosine triphosphate (ATP) levels [59,60].”
MethodCaballero, D., Palacios, L. S., Freitas, P. P., & Samitier, J. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702322 · Cited by 31
Azadi, M., Jamali, T., Kianmehr, Z., Kavoosi, G., & Ardestani, S. K. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112865 · Cited by 31
Mohammad-Hadi, L., Yaghini, E., MacRobert, A. J., & Loizidou, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093203 · Cited by 31
3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects
Harris, G., Högberg, H. T., Härtung, T., & Smirnova, L. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.29 · Cited by 31
Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions
Karunakaran, K. B., Yanamala, N. V. K., Boyce, G., Becich, M. J., & Ganapathiraju, M. K. (2021) · Cancers · doi:10.3390/cancers13071660 · Cited by 30
Tackling Ischemic Reperfusion Injury With the Aid of Stem Cells and Tissue Engineering
Zamorano, M., Castillo, R. L., Beltrán, J. F., Herrera, L., Farias, J. A., Antileo, C., Aguilar-Gallardo, C., Pessoa, A., Calle, Y., & Farías, J. G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705256 · Cited by 30
“Thus, their functionalization to drive cell fate, attract cells from the surroundings, and form a direct interface between the scaffold and the injury site is desired (Zanoni et al., 2016).”
BackgroundAnti-Cancer Drug Screening with Microfluidic Technology
Monjezi, M., Rismanian, M., Jamaati, H., & Kashaninejad, N. (2021) · Applied Sciences · doi:10.3390/app11209418 · Cited by 30
Kessel, S. L., Cribbes, S., Bonasu, S., Rice, W., Qiu, J., & Chan, L. L. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23143 · Cited by 30
Calpe, B., & Kovacs, W. J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1756769 · Cited by 30
“Measuring ATP through the acid phosphatase assay or CellTiter-Glo® 3D Cell Viability Assay [19] has shown a better correlation with the total number of cells in the MTS. ATP measurement requires however to lyse the MTS and can only be used as a final endpoint.”
BackgroundMethodInfluentialCristaldi, D. A., Sargenti, A., Bonetti, S., Musmeci, F., Delprete, C., Bacchi, F., Pasqua, S., Cavallo, C., Bonsi, L., Alviano, F., et al. (2020) · Micromachines · doi:10.3390/mi11050465 · Cited by 30
Self-citationKoch, M. K., Jaeschke, A., Murekatete, B., Ravichandran, A., Tsurkan, M. V., Werner, C., Soon, P., Hutmacher, D. W., Haupt, L. M., & Bray, L. J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.036 · Cited by 31
Chen, Y.-Q., Kuo, J.-C., Wei, M.-T., Chen, Y.-C., Yang, M.-H., & Chiou, A. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.046 · Cited by 29
Goodarzi, S., Prunet, A., Rossetti, F., Bort, G., Tillement, O., Porcel, E., Lacombe, S., Wu, T.-D., Guerquin-Kern, J.-L., Delanoë-Ayari, H., et al. (2021) · Lab on a Chip · doi:10.1039/d1lc00192b · Cited by 29
Macartney, R. A., Das, A., Imaniyyah, A. G., Fricker, A. T. R., Smith, A. M., Fedele, S., Roy, I., Kim, H., Lee, D., & Knowles, J. C. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314241313458 · Cited by 29
“103 In relation to the feasibility of using these models in drug development one should also consider the propensity for data collection from assays readily conducted in drug discovery investigations.”
Goertzen, C., Eymael, D., & Magalhães, M. A. O. (2018) · Biological Procedures Online · doi:10.1186/s12575-018-0085-6 · Cited by 29
“Several methods for generation of s tumor spheroids have been reported before and the strengths and weaknesses of these models has been reviewed before [24].”
BackgroundMethodDevices and techniques used to obtain and analyze three‐dimensional cell cultures
Agrawal, G., Ramesh, A., Aishwarya, P., Samson, J. S., & Ravi, M. (2021) · Biotechnology Progress · doi:10.1002/btpr.3126 · Cited by 29
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Buzzetti, M., Morlando, S., Solomos, D., Mehmood, A., Cox, A. W. I., Chiesa, M., D’Alessandra, Y., Garofalo, M., Topham, C. H., & Leva, G. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-84082-3 · Cited by 29
Nascimento, C. S., Castro, F., Domingues, M., Lage, A. C. P., Alves, É. A. R., Junior, R. D. J. O., de Melo, C. P., Calzavara-Silva, C. E., & Sarmento, B. F. C. C. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122866 · Cited by 29
A549 and MRC-5 cell aggregation in a microfluidic Lab-on-a-chip system
Żuchowska, A., Jastrzębska, E., Żukowski, K., Chudy, M., Dybko, A., & Brzózka, Z. (2017) · Biomicrofluidics · doi:10.1063/1.4979104 · Cited by 29
Kwakwa, K. A., Vanderburgh, J. P., Guelcher, S. A., & Sterling, J. A. R. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0385-9 · Cited by 29
Three-dimensional nanofiber scaffolds with arrayed holes for engineering skin tissue constructs
Fu, L., Xie, J., Carlson, M. A., & Reilly, D. A. (2017) · MRS Communications · doi:10.1557/mrc.2017.49 · Cited by 29
Dou, X., Li, P., & Schönherr, H. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01345 · Cited by 29
Multifunctional Compounds for Activation of the p53‐Y220C Mutant in Cancer
Miller, J. J., Orvain, C., Jozi, S., Clarke, R. M., Smith, J. R., Blanchet, A., Gaiddon, C., Warren, J. J., & Storr, T. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802677 · Cited by 29
Dhiman, N., Shagaghi, N., Bhave, M. R., Sümer, H., Kingshott, P., & Rath, S. N. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900285 · Cited by 29
A coupled mass transport and deformation theory of multi-constituent tumor growth
Faghihi, D., Feng, X., Lima, E. A. B. F., Oden, J. T., & Yankeelov, T. E. (2020) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2020.103936 · Cited by 29
“These figures indicate that the proposed mixture theory can characterize the development of heterogeneous morphology and invasive patterns as observed in both in vivo and in vitro experiments [52, 129, 162, 168].”
ResultZanotelli, V. R., Leutenegger, M., Lun, X., Georgi, F., de Souza, N., & Bodenmiller, B. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209798 · Cited by 28
“81 We grew spheroids from four widely used epithelial cell lines that reproducibly form 82 smooth spheroids [25].”
MethodIn vitro Characterization of Insulin−Producing β-Cell Spheroids
Ntamo, Y., Samodien, E., Burger, J., Muller, N., Muller, C. J. F., & Chellan, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.623889 · Cited by 28
“Keywords: 3D culture spheroids, β-cell, transmission electron microscopy, insulin secretion, viability INTRODUCTION Cell culture has been widely employed over the years to answer biologically relevant questions in various research fields (Figliolini et al., 2014; Zanoni et al., 2016).”
BackgroundBX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
Chilamakuri, R., Rouse, D. C., Yu, Y., Kabir, A., Muth, A., Yang, J., Lipton, J. M., & Agarwal, S. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101272 · Cited by 28
Mary, G., Malgras, B., Perez, J. E., Nagle, I., Luciani, N., Pimpie, C., Asnacios, A., Pocard, M. D., Reffay, M., & Wilhelm, C. (2022) · Cancers · doi:10.3390/cancers14020366 · Cited by 28
“Furthermore, their drug response resembles that of in vivo tumors [25,26].”
Ek, F., Blom, K., Selvin, T., Rudfeldt, J., Andersson, C. R., Senkowski, W., Bréchot, C., Nygren, P., Larsson, R. L., Jarvius, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12519-4 · Cited by 28
Arora, L., Kalia, M., Dasgupta, S., Singh, N., Verma, A. K., & Pal, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.881207 · Cited by 28
Markowski, A., Zaremba-Czogalla, M., Jaromin, A., Olczak, E., Zygmunt, A., Etezadi, H., Boyd, B. J., & Gubernator, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010179 · Cited by 28
Live Cell Imaging of Viscosity in 3D Tumour Cell Models
Shirmanova, M. V., Shimolina, L. E., Lukina, M. M., Вадимовна, З. Е., & Kuimova, M. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67358-5_10 · Cited by 28
Muddineti, O. S., Kumari, P., Ghosh, B., & Biswas, S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2382-9 · Cited by 28
Štarha, P., Trávníček, Z., Crlíková, H., Vančo, J., Kašpárková, J., & Dvořák, Z. (2018) · Organometallics · doi:10.1021/acs.organomet.8b00415 · Cited by 28
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Matossian, M. D., Burks, H. E., Elliott, S. G., Hoang, V. T., Bowles, A. C., Sabol, R. A., Wahba, B., Anbalagan, M., Rowan, B. G., Abazeed, M. E., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5401-2 · Cited by 28
Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation
Negrón, K., Khalasawi, N., Lu, B., Ho, C.-Y., Lee, J., Shenoy, S., Mao, H., Wang, T., Hanes, J. S., & Suk, J. S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.010 · Cited by 28
“However, conventional 2D cultures are limited in recapitulating the highly complex and heterogeneous nature of tumors established in living organisms, including humans [24, 25].”
BackgroundCalitz, C., Pavlović, N., Rosenquist, J., Zagami, C., Samanta, A., & Heindryckx, F. (2020) · Journal of Visualized Experiments · doi:10.3791/61606 · Cited by 27
Foster, N. C., Hall, N. M., & Haj, A. J. E. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0354 · Cited by 27
“89 The use of conical multiwell plates for generation of the constructs and the subsequent application of imaging software to select only the most spherical has been suggested by one group as the best means of eliminating variability.”
Rapid Formation of Stem Cell Spheroids Using Two-Dimensional MXene Particles
Jang, J., & Lee, E. (2021) · Processes · doi:10.3390/pr9060957 · Cited by 27
Decarli, M. C., de Castro, M. V., Nogueira, J. A., Nagahara, M. H. T., Westin, C. B., de Oliveira, A. L. R., da Silva, J. V. L., Moroni, L., Mota, C., & Moraes, Â. M. (2022) · Biomaterials Advances · doi:10.1016/j.msec.2022.112685 · Cited by 27
Sogomonyan, A. S., Shipunova, V. O., Soloviev, V. D., Larionov, V., Kotelnikova, P. A., & Deyev, S. M. (2022) · Acta Naturae · doi:10.32607/actanaturae.11603 · Cited by 27
Kumbham, S., Ghosh, A., Ghosh, B., & Biswas, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.250 · Cited by 27
Optimization of Tumor Spheroid Preparation and Morphological Analysis for Drug Evaluation
Lee, J. H., Kim, Y., Lim, J., Jung, H., Castellani, G., Piccinini, F., & Kwak, B. (2024) · BioChip Journal · doi:10.1007/s13206-024-00143-5 · Cited by 27
“Additionally, the morphological indicators of tumor spheroid can provide insights into the metastatic characteristics [17], as well as the surface uniformity of spheroids significantly influencing drug responsiveness [18].”
Self-citationPiccinini, F., Tesei, A., Zanoni, M., & Bevilacqua, A. (2017) · BioTechniques · doi:10.2144/000114609 · Cited by 27
Self-citationMicrofluidic device for expedited tumor growth towards drug evaluation
Uhl, C. G., & Liu, Y. (2019) · Lab on a Chip · doi:10.1039/c8lc01250d · Cited by 27
Li, X., Hattori, A., Takahashi, S., Gotö, Y., Harada, H., & Kakeya, H. (2019) · Cancer Science · doi:10.1111/cas.14236 · Cited by 27
Prostate Cancer Spheroids: A Three-Dimensional Model for Studying Tumor Heterogeneity
Rodríguez‐Dorantes, M., Cruz-Hernández, C. D., Cortés-Ramírez, S. A., Cruz-Burgos, M., Reyes‐Grajeda, J. P., Peralta-Zaragoza, Ó., & Losada-García, A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0759-6_2 · Cited by 27
Roberge, C. L., Kingsley, D. M., Faulkner, D. E., Sloat, C. J., Wang, L., Barroso, M., Intes, X., & Corr, D. T. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.09.042 · Cited by 27
Komarnicka, U. K., Pucelik, B., Wojtala, D. B., Lesiów, M. K., Stochel, G., & Kyzioł, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-03352-2 · Cited by 27
Sarkar, S., Moitra, P., Bera, S., & Bhattacharya, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c04893 · Cited by 26
In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
Salata, G. C., Hirokawa, C. M., de Melo, G. B., Malagó, I. D., Nunes, J. R., Passos, J. S., Daré, R. G., & Lopes, L. B. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00321-6 · Cited by 26
Kock, A., Bergqvist, F., Steinmetz, J. L., Elfman, L. H. M., Korotkova, M., Johnsen, J. I., Jakobsson, P., Kogner, P., & Larsson, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000684r · Cited by 27
Models for Translational Proton Radiobiology—From Bench to Bedside and Back
Suckert, T., Nexhipi, S., Dietrich, A., Koch, R. A., Kunz‐Schughart, L. A., Bahn, E., & Beyreuther, E. (2021) · Cancers · doi:10.3390/cancers13164216 · Cited by 26
Vaidyanathan, K., Wang, C., Krajnik, A., Yu, Y., Choi, M., Lin, B., Jang, J., Heo, S., Kolega, J. J., Lee, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02683-4 · Cited by 26
Qi, X., Prokhorova, A. V., Mezentsev, A. V., Shen, N., Trofimenko, A. V., Filkov, G. I., Sulimanov, R. A., Makarov, V., & Durymanov, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113306 · Cited by 26
“It should be noted that ATP level is a relevant measure of spheroid viability because the used reagent penetrates into spheroids of up to 650 μm in diameter [22].”
BackgroundMethodDigby, E. M., Ayan, S., Shrestha, P., Gehrmann, E. J., Winter, A. H., & Beharry, A. A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01504 · Cited by 26
Bourreau, C., Treps, L., Faure, S., Fradin, D., & Clere, N. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108347 · Cited by 26
Obata, T., Tsutsumi, K., Ueta, E., Oda, T., Kikuchi, T., Ako, S., Fujii, Y., Yamazaki, T., Uchida, D., Matsumoto, K., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102054 · Cited by 26
“61 Thus, in this study, to investigate the potential for further clinical applications of miR-451a, a 3D tumor spheroid culture model composed of cells in different proliferative and metabolic states 62 – 64 was employed.”
MethodPark, J., Lee, G.-H., Park, J. Y., Lee, J. C., & Kim, H. C. (2017) · Biofabrication · doi:10.1088/1758-5090/aa9472 · Cited by 26
Surface-enhanced Raman spectroscopy based 3D spheroid culture for drug discovery studies
Altunbek, M., Çetin, D., Suludere, Z., & Çulha, M. (2018) · Talanta · doi:10.1016/j.talanta.2018.08.087 · Cited by 26
Formation of size-controllable tumour spheroids using a microfluidic pillar array (μFPA) device
Lim, W., Hoang, H.-H., You, D., Han, J., Lee, J. E., Kim, S., & Park, S. (2018) · The Analyst · doi:10.1039/c8an01752b · Cited by 26
A 3D spheroid model for assessing nanocarrier-based drug delivery to solid tumors
Yadav, C., Evtushenko, A. S., Bistrović, A., Lozano‐Torres, B., Ahmed, I., Dvinskikh, L., Kaminski, C. F., & Fruk, L. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00041-x · Cited by 25
Mansouri, M., & Leipzig, N. D. (2021) · Biophysics Reviews · doi:10.1063/5.0048837 · Cited by 26
Porto, V., Buceta, D., Domínguez, B., Carneiro, C., Borrajo, E., Fraile, M., Davila‐Ferreira, N., Arias, I. R., Blanco, J. M., Blanco, M. C., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202113028 · Cited by 25
Biophysical properties of hydrogels for mimicking tumor extracellular matrix
Cameron, A. P., Zeng, B., Liu, Y., Wang, H., Soheilmoghaddam, M., Cooper-White, J. J., & Zhao, C. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212782 · Cited by 25
Focused Ultrasound Treatment of a Spheroid In Vitro Tumour Model
Landgraf, L., Kozlowski, A., Zhang, X., Fournelle, M., Becker, F.-J., Tretbar, S. H., & Melzer, A. (2022) · Cells · doi:10.3390/cells11091518 · Cited by 25
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
Cardama, G. A., Maggio, J., Capuccino, L. V., González, N., Matiller, V., Ortega, H. H., Pérez, G., Demarco, I. A., Spitzer, E., Gomez, D. E., et al. (2022) · Cancers · doi:10.3390/cancers14194810 · Cited by 25
“After approximately 7 days after the transfer, spheroids showed proper sphericity [18] and a minimum diameter of 200 μm.”
BackgroundMethodUtility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
Weth, F. R., Peng, L., Paterson, E., Tan, S. T., & Gray, C. (2022) · Cells · doi:10.3390/cells12010153 · Cited by 25
Flores-Torres, S., Jiang, T., Kort-Mascort, J., Yang, Y. K., Peza-Chavez, O., Pal, S., Mainolfi, A., Pardo, L. A., Ferri, L. E., Bertos, N., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00998 · Cited by 25
Collagen-Laponite Nanoclay Hydrogels for Tumor Spheroid Growth
Alamán‐Díez, P., Borau, C., Guerrero, P. E., Amaveda, H., Mora, M., Fraile, J. M., García‐Gareta, E., García‐Aznar, J. M., & Pérez, M. Á. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00257 · Cited by 25
Coperchini, F., Greco, A., Croce, L., Teliti, M., Calì, B., Chytiris, S., Magri, F., & Rotondi, M. (2024) · Environment International · doi:10.1016/j.envint.2024.108717 · Cited by 26
Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2
Xiang, Y., Shan, W., & Huang, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.011 · Cited by 25
“The three-dimensional tumor spheroid bridges the gap between 2D monolayer culture and solid tumor in vivo (Hirschhaeuser et al., 2010; Helmlinger et al., 1997; Zanoni et al., 2016).”
BackgroundInduced pluripotent stem cells: A new strategy to model human cancer
Bindhya, S., Sidhanth, C., Shabna, A., Krishnapriya, S., Garg, M., & Ganesan, T. S. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.008 · Cited by 25
do Amaral, R. L. F., Zimmermann, M., Ma, A., Zhang, H., Swiech, K., & Pan, C.-X. (2020) · Cancers · doi:10.3390/cancers12051304 · Cited by 25
Yan, F., Gunay, G., Valerio, T. I., Wang, C., Wilson, J. A., Haddad, M., Watson, M., Connell, M. O., Davidson, N., Fung, K.-M. A., et al. (2021) · Biomedical Optics Express · doi:10.1364/boe.425512 · Cited by 25
Dube, T., Kumar, N., Bishnoi, M., & Panda, J. J. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00321 · Cited by 24
Two-Dimensional and Three-Dimensional Cell Culture and Their Applications
Ballav, S., Deshmukh, A. J., Siddiqui, S., Aich, J., & Basu, S. (2021) · Biochemistry · doi:10.5772/intechopen.100382 · Cited by 24
“There is a gradient of nutrients across these spheroids due to which the cells at the surface of spheroids proliferate more as compared to the cells that are present in the interior [10].”
BackgroundRabie, A. M. I., Ali, A. S. M., Al‐Zeer, M. A., Barhoum, A., El-hallouty, S. M., Shousha, W. G., Berg, J., Kurreck, J., & Khalil, A. S. G. (2022) · ACS Omega · doi:10.1021/acsomega.1c05646 · Cited by 24
Lotsberg, M. L., Røsland, G. V., Rayford, A. J., Dyrstad, S. E., Ekanger, C. T., Lü, N., Frantz, K., Stuhr, L. E. B., Ditzel, H. J., Thiery, J. P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.818437 · Cited by 24
“The model represents many aspects of the tissue or tumor of interest, including 3D geometry, chemical and physical gradients such as oxygen and nutrient availability and stiffness, cell-cell and cellECM interactions (36, 39, 51, 52).”
BackgroundAdvancements in melanoma cancer metastasis models
Melo, L. M. N., Kumar, S., Riess, V., Szylo, K. J., Eisenburger, R. T., Schadendorf, D., Ubellacker, J. M., & Tasdogan, A. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13078 · Cited by 24
“…microscopy imaging, quantitative real- time PCR, ELISA, cell surface staining, and flow cytometry methods can be applied to gain detailed insights into relevant aspects of melanoma tumor progression (Beaumont et al., 2015; Ghosh, Rosenthal, et al., 2005; Haass et al., 2014; Zanoni et al., 2016).”
BackgroundMethodInfluentialAscione, F., Ferraro, R., Dogra, P., Vittorio Cristini, C., Guido, S., & Caserta, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-69570-6 · Cited by 24
Metadata
- Authors
- Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A.
- Affiliations
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- University of Bologna (IT)
- Istituto Ortopedico Rizzoli (IT)
- Corresponding author
- Tesei, Anna
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-01-11
- Volume
- 6
- Issue
- 1
- Pages
- 19103-19103
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4707510
- OpenAlex
- W2236643502
- Cited by
- 1,144
- References
- 43
- Citations by year
- 2026: 97 · 2025: 127 · 2024: 124 · 2023: 105 · 2022: 112 · 2021: 117 · 2020: 138 · 2019: 118 · 2018: 118 · 2017: 70 · 2016: 17
- FWCI
- 57.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Funders
- Ministero della Salute
- Istituto Ortopedico Rizzoli di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- tumor spheroids, spheroid morphology, automated image analysis, viability assay, cytotoxicity assay
- MeSH terms
- Cell Survival, Drug Screening Assays, Antitumor, Fibroblasts, Humans, Models, Biological, Tumor Cells, Cultured, Reproducibility of Results, Spheroids, Cellular, Imaging, Three-Dimensional, Cell Shape
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.